Brennan Troyen A 4

4 · CVS HEALTH Corp · Filed Oct 28, 2021

Form 4

Period: 2021-10-26

Chief Medical Officer

Transactions

Exercise/Conversion
Common Stock
2021-10-26$54.19/sh+80,802$4,378,660→ 221,003.059 total
Sale
Common Stock
2021-10-26$88.00/sh−1,955$172,040→ 219,048.059 total
Exercise/Conversion
Stock Option
2021-10-26−80,802→ 80,803 total
Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (80,802 underlying)
Sale
Common Stock
2021-10-26$88.00/sh−80,802$7,110,576→ 138,246.059 total

Holdings

Stock Option
Exercise: $102.26From: 2016-04-01Exp: 2022-04-01→ Common Stock (47,937 underlying)
47,937
Stock Option
Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (21,894 underlying)
21,894
Stock Option
Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (99,344 underlying)
99,344
Stock Option
Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (112,637 underlying)
112,637
Common Stock (restricted)
4,805
Stock Option
Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (75,134 underlying)
75,134
Stock Option
Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (53,772 underlying)
53,772

Footnotes (9)

[F1]All sales were effected pursuant to a Rule 10b5-1 plan.
[F2]Option became exercisable in four equal annual installments, commencing 4/1/2020.
[F3]Option became exercisable in four equal annual installments, commencing 4/1/2016.
[F4]Option became exercisable in four equal annual installments, commencing 4/1/2017.
[F5]Option became exercisable in four equal annual installments, commencing 4/3/2018.
[F6]Option became exercisable in four equal annual installments, commencing 4/1/2019.
[F7]The number of shares subject to the option were calculated using a 30-day average price.
[F8]Options became exercisable in four equal annual installments, commencing 4/1/2021.
[F9]Option becomes exercisable in four equal annual installments, commencing 4/1/2022.

Documents

1 file